Can a step test measure fitness in scleroderma patients?
Part of Skin clinical trials.
This study tests if a simple step test (stepping on and off a small step for a few minutes) is a good way to check exercise ability in people with scleroderma. It will measure how your body responds to exercise, which may help guide your treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be able to walk on your own without any walking aid.
- You cannot have chronic lung disease (COPD), a history of heart attack, or heart failure.
- You cannot have serious or unstable health problems that limit how much you can exercise.
- You cannot have severe joint or muscle problems, or have had knee or hip replacement surgery.
- You cannot have uncontrolled high blood pressure or be unable to understand and follow the test instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study tests a home-based exercise program to see if it improves quality of life for people with systemic sclerosis (scleroderma). You would do the exercises on your own, and researchers would check in with you using email questionnaires.
This study tests if a special exercise program based on your body and mind can help people with scleroderma feel better. It is for both children (ages 7-18) and adults.
This study tests whether progressive muscle relaxation exercises can help reduce fatigue and shortness of breath while improving lung function in people with scleroderma. Participants will learn and practice these exercises as part of the study.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study is testing a new scale to measure what it's like to live with hand problems caused by systemic sclerosis (scleroderma). By answering questions about your daily hand function, you can help doctors better understand your experience and improve care.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.